Opinion

Video

Hepatic Artery Infusion in Practice

Author(s):

Ryan Merkow, MD, MS,Louise Catherine Connell, MB BCh BAO, BMedSc

Turning the focus of the conversation to clinical practice, experts on hepatic artery infusion therapy provide clinical insights on program development and evolution.

Related Videos
1 expert in this video
1 expert in this video
James J. Harding, MD, associate attending physician, Memorial Sloan Kettering Cancer Center
Diane Reidy-Lagunes, MD, vice chair, Oncology Operations, Regional Care Network, Memorial Sloan Kettering Cancer Center
Yelena Y. Janjigian, MD, chief, Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center
1 expert in this video
1 expert in this video
Related Content
OncLive - stock.adobe.com
December 2nd 2024

Revisit Every OncLive On Air Episode From November 2024

OncLive On Air
September 11th 2024

Oncology Experts Preview Top Abstracts From the 2024 ESMO Congress

Suneel Kamath, MD
November 30th 2024

Targeted Therapies Remain Central to Ongoing Research in Pancreatic Cancer

Komal Jhaveri, MD, FACP, section head, Endocrine Therapy Research Program, clinical director, Early Drug Development Service, Patricia and James Cayne Chair for Junior Faculty, Memorial Sloan Kettering Cancer Center
August 22nd 2024

Jhaveri on the INAVO120 Trial of Inavolisib/Palbociclib/Fulvestrant in PIK3CA -Mutant, HR+ Breast Cancer

Alan P. Venook, MD, of UCSF
November 27th 2024

Targeted Therapies Represent Core 2024 NCCN GI Cancer Guideline Advancements

Nataliya Uboha, MD, PhD, of University of Wisconsin School of Medicine and Public Health
November 27th 2024

Discussions Swirl on the Role of PD-1 Inhibitors for Gastric/GEJ/ESCC Cancers With 1%-10% PD-L1 Expression